News Hanmi Pharm. Co., Ltd.

Equities

A128940

KR7128940004

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-16 pm EDT			5-day change	1st Jan Change
297,500 ^KRW	-0.83%		-2.78%	-15.60%

Mar. 19	Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 31	Aptose Biosciences Inc. announced that it has received $4 million in funding from Hanmi Pharm. Co., Ltd.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19	CI
Aptose Biosciences Inc. announced that it has received $4 million in funding from Hanmi Pharm. Co., Ltd.	Jan. 30	CI
Aptose Biosciences Inc. announced that it expects to receive $4 million in funding from Hanmi Pharm. Co., Ltd.	Jan. 24	CI
Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Allergic Rhinitis Pipeline, Clinical Trials, Key Companies	Nov. 08	AQ
Hanmi Pharm's Q3 Income Surges 94%	Nov. 02	MT
Allergic Rhinitis Pipeline, Clinical Trials Assessment, and FDA Approvals 2023 (Updated)	23-09-28	AQ
AffaMed Therapeutics Announces Clinical Trial Application Approval in Mainland China for Risuteganib First-in-Class Candidate for the Treatment of Intermediate Dry AMD	23-09-26	AQ
Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Aptose Biosciences Inc. announced that it expects to receive $6.999998 million in funding from Hanmi Pharm. Co., Ltd.	23-08-09	CI
Hanmi Pharm's Net Income Declines in Q2	23-08-01	MT
Assertio Holdings, Inc. (NasdaqCM : ASRT) completed the acquisition of Spectrum Pharmaceuticals, Inc. (NasdaqGS : SPPI).	23-07-30	CI
Hanmi Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Hanmi Pharm's Net Income Climbs in Q1	23-04-26	MT
Assertio Holdings, Inc. (NasdaqCM : ASRT) entered into a definitive agreement to acquire Spectrum Pharmaceuticals, Inc. (NasdaqGS : SPPI) for approximately $250 million.	23-04-24	CI
Hanmi Pharm. Co., Ltd.'s Combination Drug for Dyslipidemia Treatment, 'Rosuzet': Confirms Non-inferiority Efficacy and Safety Compared to Monotherapy in The Lancet' & 'European Heart Journal	23-03-17	CI
Advanced Gastric Carcinoma Pipeline Assessment of Active Pipeline Assets Segmented by Stage, Product Type, Route of Administration, and Molecule Type	23-03-14	AQ
Hanmi Pharm's Net Income Plunges 23.7% in Q4	23-02-09	MT
Hanmi Pharm. Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Hanmi Pharm's Net Profit Jumps 11.5% in Q3	22-11-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hanmi Pharm. Co., Ltd.

Equities

A128940

KR7128940004

Summary

Filters